Myriad Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	115.2	149.6	102.4	132.1	56.9	257.4
Short-Term Investments	-	-	-	8.8	58	81.4
Cash & Short-Term Investments	115.2	149.6	102.4	140.9	114.9	338.8
Cash Growth	54.84%	46.09%	-27.32%	22.63%	-66.09%	124.82%
Accounts Receivable	109.5	115.3	121.2	114.3	101.6	91.3
Inventory	30.6	30.6	27.5	22	20.1	15.3
Other Current Assets	33.7	37.1	46.9	36.4	38	39.4
Total Current Assets	289	332.6	298	313.6	274.6	484.8
Net Property, Plant & Equipment	158.9	163.4	172.4	180.6	187.3	125.3
Other Intangible Assets	139	153.4	262.4	349.5	379.7	404.1
Goodwill	47.1	51.6	286.3	287.4	286.8	239.2
Long-Term Investments	-	-	-	-	54.8	59
Other Long-Term Assets	4.9	5.6	8.5	15.4	15.5	8.3
Total Assets	638.9	706.6	1,028	1,147	1,199	1,321
Accounts Payable	30.4	30	32.3	25.8	28.8	29.6
Accrued Expenses	93	96.9	119	113.9	94.3	161.7
Current Portion of Leases	7.3	6.9	12.8	16.2	14.1	13
Total Current Liabilities	130.7	133.8	164.1	155.9	137.2	204.3
Long-Term Debt	120.7	119.9	39.6	38.5	-	-
Long-Term Leases	82.5	83	87.9	97.4	130.9	79.3
Other Long-Term Liabilities	1.1	1.9	34.9	71.5	44.8	69.3
Total Long-Term Liabilities	204.3	204.8	162.4	207.4	175.7	148.6
Total Liabilities	335	338.6	326.5	363.3	312.9	352.9
Common Stock	1	0.9	0.9	0.9	0.8	0.8
Additional Paid-in Capital	1,502	1,489	1,458	1,416	1,260	1,226
Accumulated Other Comprehensive Income	0.8	0.8	-0.8	-3.7	-8.9	-5.1
Retained Earnings	-1,200	-1,123	-756.8	-629.5	-366.2	-254.2
Shareholders' Equity	303.9	368	701.1	783.2	885.8	967.8
Total Liabilities & Equity	638.9	706.6	1,028	1,147	1,199	1,321
Total Debt	210.5	209.8	140.3	152.1	145	92.3
Net Cash (Debt)	-95.3	-60.2	-37.9	-11.2	-30.1	246.5
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.02	-0.65	-0.42	-0.14	-0.37	3.16
Book Value	303.9	368	701.1	783.2	885.8	967.8
Book Value Per Share	3.24	3.97	7.74	9.46	10.99	12.41
Tangible Book Value	117.8	163	152.4	146.3	219.3	324.5
Tangible Book Value Per Share	1.26	1.76	1.68	1.77	2.72	4.16

SEC Filings: 10-K · 10-Q